Cargando…
Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages
The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human health, economy, and social life worldwide. As a counteraction for this devastating disease, a number of vaccines are being developed with unprecedented speed combined with new technologies. As COVID-19 vaccines ar...
Autores principales: | Lee, Pureum, Kim, Chang-Ung, Seo, Sang Hawn, Kim, Doo-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937514/ https://www.ncbi.nlm.nih.gov/pubmed/33728097 http://dx.doi.org/10.4110/in.2021.21.e4 |
Ejemplares similares
-
Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19
por: Lee, Pureum, et al.
Publicado: (2020) -
Designing epitope-focused vaccines via antigen reorientation
por: Xu, Duo, et al.
Publicado: (2022) -
Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activating Toll-like receptor 4 and the NLRP3 inflammasome
por: Kim, Chang-Ung, et al.
Publicado: (2022) -
Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model
por: Jeong, Ahn Young, et al.
Publicado: (2023) -
Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)